ZIZIOLI, Valentina
 Distribuzione geografica
Continente #
NA - Nord America 373
EU - Europa 109
AS - Asia 60
AF - Africa 1
OC - Oceania 1
SA - Sud America 1
Totale 545
Nazione #
US - Stati Uniti d'America 372
CN - Cina 44
UA - Ucraina 32
IT - Italia 22
DE - Germania 19
HK - Hong Kong 14
FI - Finlandia 10
GB - Regno Unito 8
IE - Irlanda 8
BE - Belgio 3
RU - Federazione Russa 3
SE - Svezia 2
AT - Austria 1
AU - Australia 1
CA - Canada 1
CL - Cile 1
ES - Italia 1
IN - India 1
KG - Kirghizistan 1
MU - Mauritius 1
Totale 545
Città #
Fairfield 55
Woodbridge 39
Chandler 32
Ashburn 31
Jacksonville 28
Houston 26
Cambridge 21
New York 16
Wilmington 16
Hong Kong 14
Princeton 14
Brescia 13
Seattle 13
Dearborn 11
Ann Arbor 9
Helsinki 9
Dublin 8
Beijing 7
Nanjing 7
Hangzhou 5
Shanghai 5
Cazzago San Martino 4
Brussels 3
Des Moines 3
Changsha 2
Jiaxing 2
Jinan 2
Nanchang 2
Bishkek 1
Chengdu 1
Dunoon 1
Falkenstein 1
Fuzhou 1
Haikou 1
Hebei 1
Kilburn 1
Lincoln 1
London 1
Los Angeles 1
Madrid 1
Melbourne 1
Orange 1
Rome 1
San Diego 1
San Francisco 1
San Mateo 1
Shenyang 1
Taiyuan 1
Taizhou 1
Tianjin 1
Toronto 1
Vienna 1
Washington 1
Totale 422
Nome #
Role of 18F-FDG PET/CT in restaging and follow-up of patients with uterine sarcomas 118
Clinical and prognostic value of 18 F-FDG PET/CT in recurrent endometrial carcinoma 109
Low Expression of Claudin-7 as Potential Predictor of Distant Metastases in High-Grade Serous Ovarian Carcinoma Patients 74
Claudin 7 downregulation is predictive of distant metastasis in high-grade serous carcinoma patients 71
Patterns of Recurrence and Clinical Outcome of Patients with Stage IIIC to Stage IV Epithelial Ovarian Cancer in Complete Response after Primary Debulking Surgery Plus Chemotherapy or Neoadjuvant Chemotherapy Followed by Interval Debulking Surgery: An Italian Multicenter Retrospective Study 69
Herpes gestationis associated with normal pregnancy or complete hydatiform mole: report of three cases 47
Pre-treatment Serum HE4 Level as a Novel Independent Prognostic Biomarker for Uterine Cervical Carcinoma Patients 46
Correction for Li et al., Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors 21
Totale 555
Categoria #
all - tutte 2.738
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.738


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201926 0 0 0 0 0 0 0 0 0 0 13 13
2019/2020131 18 2 3 10 6 17 20 17 15 16 2 5
2020/2021135 3 19 6 9 11 15 7 20 8 19 8 10
2021/202253 3 6 2 3 1 4 0 6 4 5 6 13
2022/202391 10 4 3 4 7 19 0 18 16 1 7 2
2023/202485 5 3 15 8 3 23 2 4 17 4 1 0
Totale 555